772
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Journal

A Case of 22q11.2 Deletion Syndrome with Peters Anomaly, Congenital Glaucoma, and Heterozygous Mutation in CYP1B1

, , , , &
Pages 92-94 | Received 06 Aug 2013, Accepted 07 Aug 2013, Published online: 11 Sep 2013
 

Abstract

We read with interest the recent publication by Tarlan and colleaguesCitation1 describing a patient with 22q11.2 deletion syndrome and ocular features of right microphthalmia and left anterior segment dysgenesis. While anterior segment dysgenesis disorders are occasionally reported with 22q11.2 deletions,Citation2–5 this remains a rare association. We report here an 8-year-old patient with 22q11.2 deletion syndrome and bilateral Peters anomaly with congenital glaucoma; in addition, our patient was found to have a single heterozygous mutation in CYP1B1, c.83C > T, p.(Ser28Trp).

Acknowledgments

The authors gratefully acknowledge the patient and her family for their participation in the research studies.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

This work was supported by the National Institutes of Health awards R01EY015518, R21DC010912 and funds provided by the Children’s Hospital of Wisconsin (EVS), and 1UL1RR031973 from the Clinical and Translational Science Award (CTSA) program.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.